Human LDL, MDA Modified

Human LDL, MDA Modified
  • Provided at a concentration of 1.0 mg/mL
Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

Malondialdehyde (MDA) Modified Low Density Lipoprotein (LDL)
Catalog Number
STA-212
Size
100 μg
Detection
N/A
SDS Download
Price
$385.00
Recent Product Citations
  1. Irmscher, S. et al. (2021). Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease. Sci Rep. 11(1):22511. doi: 10.1038/s41598-021-02011-w.
  2. Krilis, M. et al. (2021). Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk. J Autoimmun. 122:102675. doi: 10.1016/j.jaut.2021.102675.
  3. Irmscher, S. et al. (2019). Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies. Nat Commun. 10(1):2961. doi: 10.1038/s41467-019-10766-0.
  4. Ye, Y. et al. (2019). Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE. Clin Immunol. pii: S1521-6616(19)30088-9. doi: 10.1016/j.clim.2019.05.004.
  5. Iype, J. et al. (2019). Differences in Self-Recognition between Secreted Antibody and Membrane-Bound B Cell Antigen Receptor. J Immunol. 202(5):1417-1427. doi: 10.4049/jimmunol.1800690.
  6. Shen, L. et al. (2015). B-1a lymphocytes attenuate insulin resistance. Diabetes. 64:593-603. 
  7. Haller, E. et al. (2014).  Gold nanoparticle–antibody conjugates for specific extraction and subsequent analysis by liquid chromatography–tandem mass spectrometry of malondialdehyde-modified low density lipoprotein as biomarker for cardiovascular risk. Anal Chim Acta. 857:53-63.